title: Minimal change nephrotic syndrome associated with rifampicin treatment.
authors.affiliation: Department of Internal Medicine III, Kurume University School of Medicine, Fukuoka, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Kohno
authors.forename: Y
authors.initials: Y
authors.lastname: Mizuta
authors.forename: T
authors.initials: T
authors.lastname: Yoshida
authors.forename: H
authors.initials: H
authors.lastname: Watanabe
authors.forename: H
authors.initials: H
authors.lastname: Nishida
authors.forename: K
authors.initials: K
authors.lastname: Fukami
authors.forename: S
authors.initials: S
authors.lastname: Iida
authors.forename: R
authors.initials: R
authors.lastname: Haramaki
authors.forename: Y
authors.initials: Y
authors.lastname: Wada
authors.forename: O
authors.initials: O
authors.lastname: Tamai
authors.forename: K
authors.initials: K
authors.lastname: Tamaki
authors.forename: S
authors.initials: S
authors.lastname: Kato
authors.forename: M
authors.initials: M
authors.lastname: Morimatsu
authors.forename: S
authors.initials: S
authors.lastname: Okuda
mesh_terms: D000328:Adult; D000904:Antibiotics, Antitubercular / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007678:Kidney Glomerulus / Q000473:pathology; D008854:Microscopy, Electron; D009402:Nephrosis, Lipoid / Q000139:chemically induced* / Q000473:pathology; D012293:Rifampin / Q000009:adverse effects*
chemical_list: D000904:Antibiotics, Antitubercular; D012293:Rifampin